DENTSPLY SIRONA Inc. XRAY Cash Flow

Dentsply sirona inc. (XRAY)
CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Sep'09	Jun'09	Mar'09
Cash flows from operating activities:
Net (loss) income
84,000	263,100	162,100	104,600	-1,052,800	-1,010,900	-1,662,600	-1,599,600	-1,528,900	-1,550,300	-792,200	-790,400	365,800	431,400	382,100	374,300	312,400	251,100	277,200	267,966	313,980	322,900	314,271	319,870	318,547	318,200	370,057	343,484	336,834	318,489	231,954	238,862	232,211	247,446	274,037	276,651	274,607	267,335	275,401	279,440	276,673	274,412	0	0	0
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation
130,500	133,200	131,100	134,500	134,500	132,900	136,800	134,000	129,700	127,300	123,500	123,600	124,000	116,600	104,500	95,400	83,300	79,100	79,700	77,675	79,130	81,200	83,155	82,182	82,554	81,600	81,492	80,842	79,663	79,456	76,490	72,037	69,048	64,039	60,904	59,789	56,803	56,868	56,991	57,152	56,422	54,087	0	0	0
Amortization of intangible assets
188,600	189,600	191,100	193,300	196,200	197,900	198,300	197,400	193,800	189,100	185,700	181,300	178,500	155,100	120,900	87,600	54,700	43,800	44,300	45,207	46,231	47,900	48,000	47,359	46,934	46,300	47,154	45,163	46,318	49,743	41,455	44,274	33,977	20,996	18,777	9,009	8,899	9,044	8,513	8,840	9,726	10,643	0	0	0
Amortization of deferred financing costs
2,700	2,700	2,800	2,800	2,700	2,700	2,700	2,600	2,600	2,600	2,800	3,700	4,100	4,500	11,600	11,200	11,300	11,300	4,400	4,515	4,558	4,600	4,658	4,693	4,846	5,000	5,138	7,246	7,145	7,045	13,772	10,414	9,219	8,023	0	0	0	-	-	-	-	-	-	-	-
Goodwill impairment
156,600	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Indefinite-lived intangible asset impairment
38,700	5,300	5,300	5,300	184,500	179,200	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred income taxes
-39,500	-37,400	-4,000	-9,600	-51,200	-62,000	-195,400	-180,400	-170,400	-143,800	-54,400	-73,800	-19,900	-110,100	-113,800	-71,800	-73,200	27,400	52,100	51,093	49,205	17,500	7,496	-25,529	-28,912	-29,200	-94,921	-69,659	-81,010	-65,527	-62,151	-99,728	-85,932	-88,402	-23,674	22,070	20,084	15,119	380	-4,241	-1,800	195	0	0	0
Stock based compensation expense
66,500	66,200	55,700	45,600	20,900	21,000	22,300	35,900	46,500	48,000	52,700	45,800	47,300	41,300	35,500	31,200	25,500	25,600	25,000	23,842	24,514	25,400	26,973	26,435	25,452	25,100	22,966	23,181	23,399	22,187	22,536	21,660	20,501	20,947	19,693	18,881	18,248	18,803	16,267	16,791	16,710	16,276	0	0	0
Restructuring and other costs - non-cash
8,300	16,100	18,500	28,200	28,900	22,500	72,300	72,800	67,400	64,700	17,100	7,400	7,700	9,700	9,700	800	41,100	43,300	43,600	51,600	10,600	5,800	0	0	0	-	-	-	-	-	-	-	-	2,460	741	-771	16	379	0	0	0	-	-	-	-
Stock option income tax benefit
-	-	-	-	-	-	-	-	-	-	-	-	-	12,700	12,900	11,600	19,600	11,600	11,700	10,551	2,431	2,100	538	1,627	1,866	2,400	4,070	8,968	9,733	13,009	5,536	-15	547	1,039	6,583	6,214	7,136	4,663	0	0	0	-	-	-	-
Net interest expense on derivatives with an other than insignificant financing element
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Equity in earnings from unconsolidated affiliates
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,600	-500	-12,343	-4,410	-400	-820	40	2,589	1,100	2,498	52	-801	-3,270	-4,787	-661	-1,073	2,351	0	0	0	-	-	-	-	-	-	-	-
Other non-cash expense (income)
4,400	20,300	7,000	10,400	18,400	-3,400	-9,500	-1,500	-38,300	-9,900	-7,800	-5,000	43,000	32,000	44,500	31,000	8,500	13,100	3,600	-5,510	-5,405	-10,000	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8,650	0	0	0
Loss (gain) on disposal of property, plant and equipment
-3,900	-3,600	-4,800	-4,600	-4,000	-4,600	-2,000	-1,800	-1,800	-1,600	-3,300	-2,700	-3,100	-2,800	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on divestiture of noncontrolling interest
0	8,700	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on sale on non-strategic businesses and product lines
-	-	-	-	-	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Excess tax benefits from share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Gain on sale of equity security
-	-	-	-	-	44,100	44,100	44,100	44,100	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other non-cash expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-
Accounts and notes receivable-trade, net
74,600	91,400	22,300	1,000	27,500	-23,500	-19,300	42,300	22,100	63,400	39,800	-9,600	-38,200	75,100	65,900	43,700	57,800	900	-10,200	1,295	-19,920	-7,200	-2,055	-8,319	17,783	32,500	36,103	43,454	24,631	12,591	13,469	-365	-4,578	-1,469	5,122	6,755	8,061	-5,115	56,876	79,887	52,217	16,942	0	0	0
Inventories, net
12,100	-13,700	-15,000	-31,100	-13,300	19,900	78,900	82,600	89,300	62,900	42,800	28,900	-18,500	-65,400	-62,900	-72,700	-48,100	-32,100	-36,800	-47,527	-28,780	-21,000	-14,184	7,127	18,500	25,400	27,747	30,458	24,866	36,792	30,217	17,163	-2,224	-21,503	-8,881	8,566	9,564	9,309	-17,581	-20,890	5,437	-27,710	0	0	0
Prepaid expenses and other current assets, net
-2,100	-13,000	-16,600	-6,500	37,800	27,100	62,100	41,400	71,400	75,000	69,900	83,200	24,700	32,400	25,200	19,800	20,800	9,500	10,700	8,232	15,949	16,100	11,637	5,532	-10,511	-26,900	-34,809	-30,693	-19,584	15,126	16,715	18,461	19,260	933	5,416	-10,917	3,721	3,705	-939	5,429	-2,475	-6,996	0	0	0
Other noncurrent assets, net
20,100	8,500	16,800	-1,900	5,000	12,700	18,300	12,600	-7,800	3,700	-2,000	-2,200	9,400	-2,600	-4,100	-4,200	-3,400	-3,300	-8,700	-4,504	-935	-4,900	1,792	849	1,867	1,100	-4,588	-5,195	12,869	-853	3,995	538	-13,271	1,560	0	0	0	-	-	-	-	-	-	-	-
Accounts payable
8,500	26,100	-33,500	-18,600	-300	7,100	45,200	28,200	16,900	44,200	17,700	2,800	29,400	7,200	-3,800	17,800	4,800	8,800	19,300	4,287	7,153	10,000	-9,701	-14,944	-17,725	-36,700	-699	3,020	-9,613	12,843	-5,409	5,367	16,775	10,816	9,223	-6,309	-1,461	2,165	2,362	18,913	6,881	-4,947	0	0	0
Accrued liabilities
40,300	45,300	-28,100	-76,200	-12,400	300	-25,600	42,900	-13,100	28,300	32,100	-20,300	-32,700	-12,200	-6,800	1,900	16,100	-4,700	-15,200	-23,672	-26,599	-12,200	2,694	-8,377	-17,543	-4,200	-9,758	217	11,652	-976	16,747	29,923	36,893	42,218	30,253	13,872	5,662	9,004	10,381	12,736	12,636	-1,708	0	0	0
Income taxes
-21,100	-15,800	10,300	29,600	38,500	12,100	16,800	-33,600	-3,200	-20,500	-23,100	18,400	-38,000	-7,700	-9,600	-49,500	-4,700	-8,100	-12,700	-13,232	-5,523	22,400	-2,144	52,702	44,119	-500	33,847	-988	-9,636	22,105	48,642	18,620	25,168	26,139	-12,310	10,815	21,103	2,786	19,045	22,895	3,127	8,104	0	0	0
Other noncurrent liabilities
-5,300	-2,200	-8,400	-9,000	-21,200	-16,500	-1,600	-5,200	14,600	8,200	1,600	9,300	600	9,000	16,700	14,800	18,300	17,100	14,800	11,368	16,716	9,200	14,805	14,632	8,922	13,200	-2,254	-5,254	10,339	-7,758	-1,332	879	-15,716	190	11,719	10,448	3,097	249	0	0	0	-	-	-	0
Net cash (used in) provided by operating activities
592,800	632,800	535,700	502,200	474,000	499,800	526,500	565,200	574,500	601,900	595,400	584,000	645,200	563,400	467,400	474,300	432,500	497,400	563,700	551,355	561,435	560,400	527,234	506,177	446,279	417,800	425,886	398,158	385,818	369,685	340,702	330,355	368,694	393,469	376,235	393,502	385,645	377,461	373,183	397,598	388,394	362,489	0	0	0
Cash flows from investing activities:
Cash paid on sale of non-strategic businesses or product lines
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Liquidation of short term investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	222	0	0	0
Capital expenditures
114,600	122,900	138,800	164,800	180,600	182,500	176,300	160,700	149,000	144,300	144,600	142,000	135,300	125,000	99,300	86,300	76,600	72,000	78,300	84,269	90,478	99,600	99,800	102,980	101,590	100,300	100,713	95,237	97,462	92,072	90,587	88,834	78,054	71,186	60,128	50,677	47,980	44,236	42,765	50,421	50,328	56,481	0	0	0
Cash paid on sale of business or product line
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash assumed in Sirona merger
-	-	-	-	-	-	-	-	-	-	-	-	-	522,300	522,300	522,300	522,300	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of company owned life insurance policies
-	-	-	-	-	-	-	-	-	-	-	-	-	1,700	1,700	3,100	3,100	1,400	0	0	0	-	-	-	-	-	-	-	-	1,577	1,577	1,577	1,577	0	0	0	0	-	-	-	-	-	-	-	-
Cash received on derivative contracts
27,000	40,300	38,800	33,100	30,700	8,000	3,700	3,100	4,100	6,500	13,900	14,700	16,800	20,100	21,000	27,100	27,800	30,700	84,700	79,826	74,936	67,200	6,528	4,975	11,664	10,800	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for acquisitions of businesses and equity investments, net of cash acquired
-	-	-	-	-	130,500	140,500	151,200	143,500	145,900	135,900	466,600	350,500	341,800	392,500	51,100	54,400	54,000	0	0	0	-	-	-	-	66,200	8,800	8,800	8,800	4,861	-10,403	1,767,429	1,781,934	1,787,516	1,811,478	47,334	33,451	35,556	21,997	8,309	10,099	2,986	0	0	0
Cash received on sale of non-strategic businesses or product lines
-	-	-	-	-	-	-	-	-	-	-	-	-	6,100	6,000	2,400	2,400	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of short-term investments
-800	0	3,600	4,000	4,500	3,700	300	200	2,400	2,500	9,100	9,100	6,900	6,800	0	0	0	-	-	-	-	2,300	2,300	1,135	1,144	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid on derivatives contracts
-	-	-	-	-	2,400	2,400	2,400	2,400	0	1,400	13,500	13,600	17,100	21,200	9,100	9,000	6,300	92,400	93,294	95,197	96,500	14,133	14,063	61,238	104,900	95,667	94,843	59,986	14,221	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Expenditures for identifiable intangible assets
-	-	-	-	-	5,500	5,500	6,100	5,200	6,700	6,700	7,000	5,900	1,100	0	0	0	-	-	-	5,095	6,200	1,351	1,453	2,200	1,100	4,182	4,104	3,388	3,329	2,927	2,924	2,960	3,068	1,652	1,683	1,753	1,606	177	-989	121	14	0	0	0
Proceeds from sale of property, plant, and equipment, net
5,200	4,800	7,200	6,000	6,500	9,200	11,600	9,400	8,800	7,400	2,200	2,500	6,200	5,000	5,000	4,500	700	400	300	623	532	600	508	1,068	1,950	3,000	3,578	2,783	2,091	1,039	457	787	611	497	3,646	3,458	3,501	3,562	4,226	5,141	5,956	5,860	0	0	0
Net cash used in investing activities
-71,200	-68,400	-88,000	-118,300	-220,800	-253,300	-255,600	-254,000	-290,500	-286,400	-282,400	-618,200	-485,500	60,000	38,500	454,400	458,000	-54,900	-49,100	-106,354	-118,358	-138,700	-174,709	-179,358	-216,319	-260,200	-196,612	-192,702	-167,545	-115,021	-121,559	-1,899,767	-1,889,483	-1,886,842	-1,940,137	-182,868	-166,315	-164,468	-79,279	-52,592	-54,428	-53,399	0	0	0
Cash flows from financing activities:
Proceeds (repayments) on short-term borrowings, net
30,200	-68,500	-131,300	-150,200	300	60,400	133,100	196,100	1,100	10,200	5,000	-39,100	-40,700	-44,100	-50,800	-39,200	-164,400	-2,200	-1,200	-30,413	-6,686	-101,900	-51,289	-21,237	106,053	57,300	-104,655	-153,281	-223,934	-228,912	154,328	235,205	277,961	270,209	1,123	-4,597	-4,130	-9,657	-16,350	-49,044	-10,634	-7,465	0	0	0
Excess tax benefits from stock based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	12,700	12,900	11,600	19,600	11,600	11,700	10,551	2,431	2,100	538	1,627	1,866	2,400	4,070	8,968	9,733	13,009	5,536	-15	547	1,039	6,583	6,214	7,136	4,663	5,368	6,168	4,811	3,505	0	0	0
Cash paid for acquisition of noncontrolling interests of consolidated subsidiaries
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	80,500	80,400	80,467	80,467	0	40	73	73	9,000	0	0	0	-	-343	-343	543	16,088	0	0	0	-	-	-	-	-	-	-	-
Cash paid for treasury stock
400,000	260,000	0	0	0	-	-	-	-	401,400	270,600	365,400	463,000	813,900	694,700	613,700	456,500	112,700	205,100	207,614	207,805	163,200	116,419	110,308	158,395	118,000	72,379	62,275	7,968	38,837	38,839	38,840	36,690	79,500	94,958	126,863	256,249	223,993	266,000	245,570	115,477	78,718	0	0	0
Cash dividends paid
83,500	80,900	78,200	78,000	78,300	78,600	79,200	79,900	80,100	78,300	76,100	74,100	72,500	64,600	56,800	49,000	40,600	40,000	39,300	38,447	37,821	37,300	36,805	36,325	35,870	34,800	33,759	32,647	31,487	31,425	30,681	30,026	29,348	28,632	27,537	27,648	28,799	29,077	30,505	30,658	29,785	29,836	0	0	0
Proceeds from long-term borrowings, net of deferred financing costs
118,000	118,900	118,700	1,500	900	100	500	500	200	3,100	382,800	1,143,600	1,143,700	1,220,600	993,600	232,800	232,800	152,900	0	0	0	-	-	-	-	-	-	-	-	-	-	-	1,059,985	1,106,514	1,451,325	156,865	107,877	368,611	0	0	0	-	-	-	0
Repayments on long-term borrowings
250,100	251,200	251,300	143,600	11,100	9,400	9,800	10,500	11,500	16,700	390,500	756,600	755,400	877,500	661,600	294,800	294,900	267,500	109,300	224,029	224,126	199,200	0	0	0	-	-	-	0	-	-	-	255,152	251,932	253,088	4,432	-55,127	242,137	241,638	243,371	304,111	58,403	0	0	0
Proceeds from exercised stock options
92,800	108,800	83,900	90,400	39,400	27,900	52,200	50,800	61,200	82,300	67,100	66,000	63,000	41,000	35,100	37,300	28,800	35,500	57,500	54,864	58,951	49,000	37,250	48,423	57,471	66,900	57,703	45,330	33,278	34,183	30,812	28,348	34,587	42,275	39,550	38,337	44,957	30,189	30,887	33,401	19,449	13,406	0	0	0
Cash paid for contingent consideration on prior acquisitions
4,200	33,200	30,700	30,600	30,600	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,519	3,762	3,024	4,804	3,023	0	0	0	-	-	-	-	-	-	-	-
Proceeds from Derivative Instrument, Financing Activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Payments for Derivative Instrument, Financing Activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	0	-	0	0	0	-	-	-	-	-	-	-	-
Net cash used in financing activities
-496,800	-466,100	-448,900	-370,500	-329,600	-249,800	-403,400	-343,100	-352,600	-400,800	-281,300	-22,100	-121,000	-526,200	-422,400	-715,000	-675,200	-302,900	-365,900	-401,255	-381,223	-336,200	-301,350	-319,709	-230,780	-161,700	-234,674	-203,631	-229,626	-255,609	-225,154	972,651	1,007,985	1,002,381	1,065,837	16,485	-91,984	-103,036	-68,447	-192,983	-146,722	-71,420	0	0	0
Effect of exchange rate changes on cash and cash equivalents
-14,300	-3,000	-5,800	-2,600	-15,300	-7,700	-4,400	2,800	22,400	22,000	7,600	13,100	1,500	2,100	10,800	1,400	7,200	-6,600	-10,000	-14,221	-17,123	-8,900	-4,101	2,870	518	-1,000	-17	1,992	210	3,949	-19,780	-21,739	4,886	28,082	45,688	104,244	42,901	-20,267	-24,582	-63,547	-8,526	8,687	0	0	0
Net decrease in cash and cash equivalents
10,500	95,300	-7,000	10,800	-91,700	-11,000	-136,900	-29,100	-46,200	-63,300	39,300	-43,200	40,200	99,300	94,300	215,100	222,500	133,000	138,700	29,525	44,731	76,600	47,074	9,980	-302	-5,100	-5,417	3,817	-11,143	3,004	-25,791	-618,500	-507,918	-462,910	-452,377	331,363	170,247	89,690	200,875	88,476	178,718	246,357	0	0	0
Non-cash investing activities:
Merger financed by common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-